Oct 25 (Reuters) - Adocia SA ADOC.PA :
* CASH POSITION OF EUR 20.1 MILLION AS OF SEPT 30
* SEEKS STRATEGIC PARTNERSHIPS TO ACCELERATE RESEARCH
PROJECTS,
RESPECT IPF PARTNERS' CASH COVENANT AT BEGINNING OF Q2 2023
* ON BIOCHAPERONE LISPRAM: CLINICAL PHASE OF STUDY RESULTS
WILL BE
COMMUNICATED IN Q4
* ON BIOCHAPERONE COMBO: PRELIMINARY RESULTS EXPECTED IN Q1
2023
* Q3 REVENUE EUR 2.4 MILLION VERSUS EUR 0.5 MILLION YEAR AGO
Source text for Eikon: ID:nBw1bg3bZa
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))